Vertex Pharmaceuticals Inc (NASDAQ:VRTX) - Share price - Overview

Stock Report

Vertex Pharmaceuticals Inc VRTX

Last Price
$158.69

Day Change
0.54|0.34%

As of 23/04/2018
16:10:11 EDT | USD
Minimum 15 Minutes Delay.

Last Close158.15
Day Range157.74 - 160.13
Mkt Cap40.31Bil
52-Wk Range113.66 - 178.25
Yield %-
ISINUS92532F1003
Volume1,097,180
P/E152.59
P/S16.10
P/CF47.56

Share Price

Financials
201520162017
More ...
Income Statement
Revenue1,032.341,702.182,488.65
Operating Income-464.6711.20392.83
Net Income-556.33-112.05263.48
Basic EPS-2.31-0.461.06
Avg. Diluted Shares Outstanding241245253
Balance Sheet
Current Assets1,407.151,831.542,648.96
Non Current Assets1,091.721,065.25897.05
Total Assets2,498.882,896.793,546.01
Current Liabilities506.35792.54807.26
Total Liabilities---
Total Equity939.971,156.582,028.58
Cash Flow
Operating Cash Flow-365.43236.10844.94
Capital Expenditure-45.30-56.56-259.42
Free Cash Flow-410.73179.54585.52

In millions, except "Basic EPS". Currency is USD.

Company Profile

Vertex Pharmaceuticals Inc is engaged in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases in specialty markets. Its products include SYMDEKO, ORKAMBI, and KALYDECO.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Large-Growth

Fiscal Year Ends

December

Employees

2,300
Key Stats
More ...
Price/Earning TTM149.20
Price/Book19.87
Price/Sales TTM16.09
Rev Growth (3 year avg)62.46
EPS Growth (3 year avg)-
Operating Margin % TTM15.78
Net Margin % TTM10.59
ROE TTM16.53
Debt/Equity0.29
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.